Provided by Tiger Trade Technology Pte. Ltd.

Virax Biolabs Group Limited

2.82
+0.09003.30%
Volume:60.67K
Turnover:173.46K
Market Cap:2.25M
PE:-0.22
High:2.92
Open:2.73
Low:2.70
Close:2.73
52wk High:21.75
52wk Low:2.50
Shares:796.90K
Float Shares:727.90K
Volume Ratio:4.32
T/O Rate:8.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-12.6400
EPS(LYR):-12.6400
ROE:-78.65%
ROA:-54.23%
PB:0.30
PE(LYR):-0.22

Loading ...

Virax Biolabs to Consolidate Shares 1-for-25 on June 26

Reuters
·
Jun 24

Virax Biolabs adjourns shareholder meeting after failing to reach quorum

Reuters
·
Jun 12

Virax Biolabs posts early pilot data for ViraxImmune Long COVID test, reports 88% specificity

Reuters
·
May 26

Virax Biolabs Reports Positive Early Clinical Data for Viraximmune™ in Long Covid and Related Post-Acute Infection Syndromes

THOMSON REUTERS
·
May 26

Virax Biolabs announces extraordinary shareholder meeting

Reuters
·
May 23

Why Is Virax Biolabs (VRAX) Stock Trending Overnight?

Benzinga
·
May 19

Virax Biolabs CEO outlines strategic priorities, near-term milestones

TIPRANKS
·
Apr 14

Virax Biolabs announces availability of shareholder letter from CEO James Foster

Reuters
·
Apr 14

Virax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to Shareholders

THOMSON REUTERS
·
Apr 14

Virax Biolabs raises $5 million in private placement via pre-funded warrants, options

Reuters
·
Apr 11

Virax Biolabs director Nelson Haight files initial beneficial ownership statement

Reuters
·
Apr 01

Virax Biolabs Group Ltd. COO and Director Nigel William McCracken files initial beneficial ownership statement

Reuters
·
Mar 20

Virax Biolabs Delays 2025 Annual Shareholder Meeting After Failing to Reach Quorum, Reschedules for March 18, 2026

Reuters
·
Mar 19

Virax Biolabs Group names director Evan Michael Norton in initial beneficial ownership filing

Reuters
·
Mar 19

Virax Biolabs Director Iain David Miller Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19